March 1, 2006

STANDARD & POOR’S FIVE STAR STOCKS
SYM ACAS ADP AES AET AKS
ALL ALTR AMR ANF APPB BAC BEN BRKS BSC C CAJ CAL CHK CHTT CIT CL CN CNX COF COH COP CSC CTCO CTL CVD CVS CVX DHR DNA DOW

Recommended by S&P analysts for superior price appreciation over the next 6-12 months.
5 STARS PRICE WHEN CURRENT SINCE RECOMMENDED PRICE CURRENT REASON 02/03/06 35.27 35.61 Valuation 10/07/03 38.44 46.21 Improving job market 04/28/04 7.7 17.50 Improving subsidiaries 02/10/05 33.5* 51.28 Strong membership gains, cost controls 01/24/06 10.16 11.38 More optimistic outlook for ’06 FCF
02/06/03 12/01/05 11/02/05 09/20/05 09/29/05 05/20/04 12/09/03 08/02/05 11/12/03 05/17/02 01/30/06 11/02/05 02/14/06 02/09/06 01/20/05 12/07/04 12/22/05 02/16/06 07/22/04 08/02/05 03/28/05 01/25/06 03/01/06 07/20/04 01/12/05 02/02/05 10/21/05 07/21/05 01/24/06 01/29/04 32.02 19.18 14.19 45.96 20.36 40.33* 48.9 16.29 75.1 44.38 61.26 13.47 28.84 37.11 40.17 50.07 32.74 62.45 69.3 34.75 54.74 21.18 25.37 67.25 23.57 45.59 103.37 16.19 134.69 46.52 63.03 24.06 30.43 39.30 53.98

COMPANY NAME Amer Capital Str Automatic Data AES Corp Aetna Inc AK Steel
Allstate Corp Altera Corp AMR Corp Abercrombie & Fi Applebee’s Bank of America Franklin Res Brooks Automatio Bear Stearns Citigroup Inc Canon Inc Contl Airlines’B Chesapeake Ene Chattem Inc CIT Group Colgate-Palmoliv China Netcom Gro CONSOL Energy Capital One Fina Coach Inc

Modestly undervalued; trend improvement Chip industry growth, valuation Improving revenues, moderating oil Valuation Strong expansion prospects Shares undervalued vs. peers Shift toward higher-margin equity funds Valuation, improving fundamentals Revenue growth, diversification Big discount to historical valuation See strong demand, better margins Improving revenue environment Higher guidance; production hedges Strong sales prospects, valuation Valuation Benefits from restructuring plan Shares undervalued relative to peers Low customer coal stockpiles Strong credit quality & loan growth Continued market share opportunities Valuation Valuation, recent US govt biz wins Valuation Below peers on multiple of metrics Valuation Increased generic drug sales, valuation Valuation Improving demand from end-markets Valuation, potential new FDA approvals Better results, business trends

ConocoPhillips Computer Science Commonwealth Tel CenturyTel Inc Covance Inc CVS Corp Chevron Corp Danaher Corp Genentech Inc Dow Chemical

S

M A
52.63* 49.41 32.28 30.95 37.34 24.13* 56.3 55.1 86.2 41.26

P
54.77 35.74 65.20 88.29 35.88 61.77 54.66 31.95 36.63 55.75 29.06 57.23 61.20 84.95 43.95

E L

*Adjusted for stock split

Page 1 of 4

#####

March 1, 2006

SYM DOX DUK EMC ENDP EON
ERTS ET FCH FDX FMC FPL GS GTRC GWW HD HIG HNT HOLX HSY IACI IM IR JEC JNJ KLAC KMP KSS LHO LLY LSTR MC MCK MER MET MFE MOT MOV MSFT MYGN MYL

COMPANY NAME Amdocs Ltd Duke Energy EMC Corp Endo Pharmaceuti E.ON AG ADS
Electronic Arts E Trade FelCor Lodging T FedEx Corp FMC Corp FPL Group Goldman Sachs Gr Guitar Center Grainger (W.W.) Home Depot Hartford Finl Health Net Hologic Hershey Co IAC/InterActiveC Ingram Micro’A’ Ingersoll-Rand’A Jacobs Engr Grou Johnson & Johnso KLA-Tencor Corp Kinder Morgan Eg Kohl’s Corp LaSalle Hotel Pr Lilly (Eli) Landstar Sys Matsushita El In McKesson Corp Merrill Lynch MetLife Inc McAfee Inc

5 STARS PRICE WHEN CURRENT SINCE RECOMMENDED PRICE CURRENT REASON 09/15/05 27.47 33.59 Positive communications industry trends 04/14/05 28.26 28.28 Higher free cash flow growth 04/28/04 11.83 14.24 Favorable industry position 07/14/05 27.97 32.11 Higher sales of generic OxyContin 02/27/06 37.74 37.27 Proposed acquistion bid for Endesa
11/14/05 03/22/04 04/07/04 12/21/05 02/03/04 10/21/05 09/21/04 03/31/04 09/29/04 09/28/05 08/05/05 02/01/06 09/16/05 01/25/06 02/09/06 09/20/05 04/06/04 01/24/06 02/08/06 02/01/06 12/12/05 12/13/05 12/08/05 12/13/05 07/18/02 10/31/05 01/27/06 01/19/06 12/07/05 08/12/04 10/03/05 01/31/06 11/04/02 12/12/05 02/03/06 59.09 12.27 10.32 103.7 33.16 42.52 94.9 35.92 56.56 37.85 77.15 48.33 26.72* 52.3 28.02 17.91 35.16* 77.21 58.6 53.44 49.93 45.65 33.6 55.7 11.94* 18.4 53.8 72.05 50.62 17.52 52.02 25.51 20.08 110.43 61.89 41.60 143.15 51.23 75.40 42.59 83.50 48.66 50.12 51.41 29.65 20.21 41.95 86.94 57.66 54.16 47.27 48.77 40.07 55.88 47.16 21.45 54.77 77.54 49.67 23.46 22.09 21.99 27.14 25.80 23.25

Valuation Co, gaining market share Valuation, industry recovery Strong growth & margin improvement Improving outlook Valuation, higher power prices Valuation Valuation Better market conditions for manfctrng Valuation-hurricane rebuilding efforts See catalysts for growth Lower medical cost trends Favorable clinical data Strong operating trends Valuation Restructuring efforts & acquisitions Expected imprvmnts in several end mkts See backlog growth for oil & gas Valuation Improving business fundamentals Solid capital appreciation potential Valuation Recent acqs, pull back in stock price Robust R&D pipeline, solid growth prods High returns on asset, equity Valuation, strong demand for plasma TVs Strong demand for high margin IT prods Strong growth, investor confidence Valuation, improving underwriting mrgns Refocus on highly profitable operations Strong wireless demand Attractive valuation Solid fundamentals; valuation Positive predictive medicine testing Recent restructuring, pipline growth

Motorola Movado Group Microsoft Myriad Genetics Mylan Labs

S

M A
22.44 18.89 28.05* 20.74 19.3

P

E L

*Adjusted for stock split

Page 2 of 4

March 1, 2006

SYM NBR NDE NE NFB ORCL
OXY PDLI PEP PETM PG PWAV RHI RNVS SANYY SIRI SLH SMTC SRCL SSCC STZ TEVA TOT TROW TXN UNH VLO WLP WMT WWY XEC XOM XRAY ZQK

COMPANY NAME Nabors Indus IndyMac Bancorp Noble Corp North Fork Banco Oracle Corp
Occidental Petro PDL BioPharma PepsiCo Inc PETsMART Inc Procter & Gamble Powerwave Techno Robert Half Renovis Inc SANYO Elec Sirius Satellite Strategic Htl Semtech Corp Stericycle Inc Smurfit-Stone Co Constellation Teva Pharm Indus Total ’B’ ADS T.Rowe Price Texas Instrument UnitedHealth Gro Valero Energy WellPoint Inc Wal-Mart Stores Wrigley (Wm) Jr Cimarex Energy Exxon Mobil DENTSPLY Intl Quiksilver

5 STARS PRICE WHEN CURRENT SINCE RECOMMENDED PRICE CURRENT REASON 12/07/01 32.11 66.86 See nat gas activity rising 04/19/01 25.75 39.20 Attractive after price dip 02/27/06 72.21 76.30 Rising jackup rig dayrates benefits 03/01/06 25.54 25.68 Valuation 02/28/06 12.42 12.80 Valuation
11/01/05 02/02/06 03/19/01 08/04/05 06/12/02 09/14/05 05/04/05 04/07/05 07/01/05 02/16/06 06/30/05 01/27/06 04/22/05 01/03/06 09/29/98 10/12/05 10/13/04 02/17/06 02/02/06 10/14/05 03/28/05 12/01/04 02/17/05 07/28/04 10/06/05 03/28/05 04/28/04 12/05/05 79.53 29.51 42.68 28.3 46.16* 12.25 25.58 6.95 13.01 5.65 18 19.06 44.18 13.71 5* 34.55 102.21 76.36 29.76 56.43 35.43* 54.55* 52.7 60.25 40.62 58.89 48.09 12.01 92.64 31.75 59.24 26.21 60.10 15.32 37.14 22.41 12.29 5.04 22.29 19.49 60.45 13.04 26.53

Valuation Royalty growth will remain very strong Reflects strong growth trends Valuation, attractive metrics Improving fundamentals Stronger wireless handset demand Higher estimates, valuation Valuation Restructuring to lower costs, focus ops Valuation Valuation Valuation, improving industry dynamics Valuation Improved containerboard industry Large discount to peers, mid-cap index Imprvd prospects, assmng the acq closes Valuation, refining margins projections Valuation Valuation, improving semicndtr industry Improved prospects from PHS acq Valuation Profits prospects improved from merger Valuation Strong operating momentum Valuation, high energy prices Valuation Excelled internal growth See FY 06 as transitional for co.

S

*Adjusted for stock split

M A

43.42 126.94 77.23 32.17 58.42 54.93 76.59 45.14 62.85 43.05 60.34 56.80 14.55

P

E L

Page 3 of 4

March 1, 2006

CHANGES LAST 5 DAYS
DATE CHANGED
3/1 3/1 2/28 2/27 2/27

SYM CTCO NFB ORCL EON NE

STOCK Commonwealth Te North Fork Banc Oracle Corp E.ON AG ADS Noble Corp

NEW RANKING $$$$$ $$$$$ $$$$$ $$$$$ $$$$$

OLD RANKING $$$$ $$$$ $$$$ $$$ $$$$

REASON WHY Valuation Valuation Valuation Proposed acquistion bid for Endesa Rising jackup rig dayrates benefits

This report is provided for information purposes only. Under no circumstances is it to be used or considered as an offer to sell, or a solicitation of any offer to buy, any security. While the information contained herein has been obtained from sources deemed to be reliable, neither S&P nor its licensors nor any party through whom the user obtains this Report guarantee that it is accurate or complete or make any warranties with regard to the results to be obtained from its use. Reproduction or redistribution of this report in any form is prohibited except with written permission. The providers of this Report, their affiliated companies or their shareholders, may have a position in the securities discussed herein.

S

M A

P

E L

Page 4 of 4